Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBk. Cyprus Hldg Regulatory News (BOCH)

Share Price Information for Bk. Cyprus Hldg (BOCH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 327.00
Bid: 326.00
Ask: 328.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.613%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 327.00
BOCH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Financial Report 2022 - 1

31 Aug 2022 07:02

RNS Number : 7196X
Bank of Cyprus Holdings PLC
31 August 2022
 

 

 

 

 

Ιnterim Financial Report 2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Contents

Page

Board of Directors and Executives

1

Forward Looking Statements and Notes

2

Interim Management Report

5

Consolidated Condensed Interim Financial statements

Interim Consolidated Income Statement

37

Interim Consolidated Statement of Comprehensive Income

38

Interim Consolidated Balance Sheet

39

Interim Consolidated Statement of Changes in Equity

40

Interim Consolidated Statement of Cash Flows

42

Notes to the Consolidated Condensed Interim Financial Statements

1. Corporate information

44

2. Unaudited financial statements

44

3. Summary of significant accounting policies

44

4. Going concern

48

5. Economic and geopolitical environment

49

6. Significant and other judgements, estimates and assumptions

50

7. Segmental analysis

57

8. Net losses on financial instruments

63

9. Staff costs and other operating expenses

64

10. Credit losses on financial instruments and impairment net of reversals of non‑financial assets

65

11. Income tax

66

12. Earnings per share

67

13. Investments

68

14. Derivative financial instruments

69

15. Fair value measurement

71

16. Loans and advances to customers

76

17. Stock of property

76

18. Prepayments, accrued income and other assets

77

19. Non‑current assets and disposal groups held for sale

78

20. Funding from central banks

79

21. Customer deposits

80

22. Debt securities in issue and Subordinated liabilities

81

23. Accruals, deferred income, other liabilities and other provisions

82

24. Share capital

82

25. Pending litigation, claims, regulatory and other matters

84

26. Contingent liabilities and commitments

91

27. Cash and cash equivalents

91

28. Analysis of assets and liabilities by expected maturity

92

29. Risk management ‑ Credit risk

93

30. Risk management ‑ Market risk

116

31. Risk management ‑ Liquidity and funding risk

121

32. Capital management

125

33. Related party transactions

126

34. Group companies

129

35. Investments in associates and joint venture

131

36. Events after the reporting period

131

Independent Review Report to the Bank of Cyprus Holdings Public Limited Company

132

Additional Risk and Capital Management Disclosures

134

Definitions and explanations of Alternative Performance Measures Disclosures

155

 

Board of Directors and Executives as at 30 August 2022

 

 

Board of Directors of Bank of Cyprus Holdings Public Limited Company

Efstratios‑Georgios Arapoglou

CHAIRMAN

 

Lyn Grobler

VICE‑CHAIRPERSON

 

 

Arne Berggren

Panicos Nicolaou

Ioannis Zographakis

Maria Philippou

Nicos Sofianos

Paula Hadjisotiriou

Constantine Iordanou

Eliza Livadiotou

 

Executive Committee

Panicos Nicolaou

CHIEF EXECUTIVE OFFICER

 

Dr. Charis Pouangare

DEPUTY CHIEF EXECUTIVE OFFICER & CHIEF OF BUSINESS

 

Eliza Livadiotou

EXECUTIVE DIRECTOR FINANCE & LEGACY

 

Demetris Th. Demetriou

CHIEF RISK OFFICER

 

Irene Gregoriou

EXECUTIVE DIRECTOR PEOPLE & CHANGE

 

George Kousis

ACTING EXECUTIVE DIRECTOR TECHNOLOGY & OPERATIONS

 

Company Secretary

Katia Santis

Legal Advisers as to matters of Irish Law

Arthur Cox

Legal Advisers as to matters of English and US Law

Sidley Austin LLP

Legal Advisers as to matters of Cypriot Law

Chryssafinis & Polyviou LLC

Statutory Auditors

PricewaterhouseCoopersOne Spencer DockNorth Wall QuayDublin 1D01 X9R7Ireland

 

Registered Office

10 Earlsfort Terrace

Dublin 2

D02 T380

Ireland

 

BANK OF CYPRUS HOLDINGS GROUP

Interim Financial Report 2022

Forward Looking Statements and Notes

 

Forward Looking Statement and Notes

This document contains certain forward looking statements which can usually be identified by terms used such as 'expect', 'should be', 'will be' and similar expressions or variations thereof or their negative variations, but their absence does not mean that a statement is not forward looking. Examples of forward‑looking statements include, but are not limited to, statements relating to the Bank of Cyprus Holdings Group's (the Group) near term and longer term future capital requirements and ratios, intentions, beliefs or current expectations and projections about the Group's future results of operations, financial condition, expected impairment charges, the level of the Group's assets, liquidity, performance, prospects, anticipated growth, provisions, impairments, business strategies and opportunities. By their nature, forward‑looking statements involve risk and uncertainty because they relate to events, and depend upon circumstances, that will or may occur in the future. Factors that could cause actual business, strategy and/or results to differ materially from the plans, objectives, expectations, estimates and intentions expressed in such forward‑looking statements made by the Group include, but are not limited to: general economic and political conditions in Cyprus and other European Union (EU) Member States, interest rate and foreign exchange fluctuations, legislative, fiscal and regulatory developments and information technology, litigation and other operational risks, adverse market conditions, the impact of outbreaks, epidemics or pandemics, such as the COVID‑19 pandemic and ongoing challenges and uncertainties posed by the COVID‑19 pandemic for businesses and governments around the world. Russian invasion of Ukraine has led to heightened volatility across global markets and to the coordinated implementation of sanctions on Russia, Russian entities and nationals. The Russian invasion of Ukraine has already caused significant population displacement, and if the conflict continues, the disruption will likely increase. The scale of the conflict and the speed and extent of sanctions, as well as the uncertainty as to how the situation will develop, may have significant adverse effects on the market and macroeconomic conditions, including in ways that cannot be anticipated. This creates significantly greater uncertainty about forward‑looking statements. Should any one or more of these or other factors materialise, or should any underlying assumptions prove to be incorrect, the actual results or events could differ materially from those currently being anticipated as reflected in such forward looking statements. The forward‑looking statements made in this document are only applicable as at the date of publication of this document. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward looking statement contained in this document to reflect any change in the Group's expectations or any change in events, conditions or circumstances on which any statement is based.

Further Information

In accordance with Rule 26.1 of the Irish Takeover Rules, a copy of this document will be available on the Company's website at https://www.bankofcyprus.com/en‑gb/group/investor‑relations/possible‑offer/ by no later than 12.00 (noon) (Irish/UK time) on the business day following publication of this document. The content of the website referred to in this document is not incorporated into, and does not form part of, this document. This document is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of, any securities, or the solicitation of any vote or approval in any jurisdiction, pursuant to this document or otherwise. Any offer will be made solely by certain offer documentation which will contain the full terms and conditions of any offer, including details of how it may be accepted.

This document has been prepared in accordance with and in compliance with the applicable laws of Ireland, Cyprus and England and information disclosed may not be the same as that which would have been prepared in accordance with the laws of other jurisdictions.

The distribution of this document in jurisdictions other than Ireland, Cyprus and the United Kingdom and the availability of any offer to shareholders of the Company who are not resident in Ireland, Cyprus or the United Kingdom may be affected by the laws of relevant jurisdictions. Therefore, any persons who are subject to the laws of any jurisdiction other than Ireland, Cyprus or the United Kingdom or shareholders of the Company who are not resident in Ireland, Cyprus or the United Kingdom will need to inform themselves about, and observe, any applicable requirements.

Jurisdiction

The Company is a public limited company incorporated in Ireland with relevant securities listed and admitted to trading on the Main Market of the London Stock Exchange and on the Cyprus Stock Exchange. As a result, any transaction to acquire the Company which constitutes a "takeover bid" (as defined in Directive 2004/25/EC (the "Takeover Bids Directive")) will be subject to the shared jurisdiction of the Irish Takeover Panel and the Cyprus Securities Exchange Commission in line with the procedures set out in Article 4 of the Takeover Bids Directive, as implemented in Ireland and Cyprus. Any transaction to acquire control of the Company which proceeds otherwise than by way of takeover bid will be subject to the jurisdiction of the Irish Takeover Panel under the Irish Takeover Rules. Prior to a determination being made as to the manner in which any transaction to acquire the Company would be implemented, the possible offer is subject to the jurisdiction of both the Irish Takeover Panel and the Cyprus Securities Exchange Commission. There is no certainty that any formal offer to acquire the Company will be made nor as to the terms on which any offer might be made.

Responsibility Statement

The Directors of the Company accept responsibility for the information contained in this document. To the best of their knowledge and belief (having taken all reasonable care to ensure such is the case), the information contained in this document is in accordance with the facts and does not omit anything likely to affect the import of such information.

Disclosure requirements of the Irish Takeover Rules

Under Rule 8.3(a) of the Irish Takeover Rules, any person who is 'interested' (directly or indirectly) in 1% or more of any class of 'relevant securities' of the Company must make an 'opening position disclosure' by no later than 3.30pm (Irish/UK time) on 2 September 2022. An 'opening position disclosure' must contain the details specified in Rule 8.6(a) of the Irish Takeover Rules, including details of the person's interests and short positions in any 'relevant securities' of the Company. Relevant persons who deal in any 'relevant securities' of the Company prior to the deadline for making an 'opening position disclosure' must instead make a dealing disclosure as described below.

Under Rule 8.3(b) of the Irish Takeover Rules, any person 'interested' (directly or indirectly) in 1% or more of any class of 'relevant securities' of the Company must disclose all 'dealings' in such 'relevant securities' during the 'offer period'. The disclosure of a 'dealing' in 'relevant securities' by a person to whom Rule 8.3(b) applies must be made by no later than 3.30 pm (Irish/UK time) on the business day following the date of the transaction. A dealing disclosure must contain the details specified in Rule 8.6(b) of the Irish Takeover Rules, including details of the dealing concerned and of the person's interests and short positions in any 'relevant securities' of the Company.

In addition, Lone Star must make an 'opening position disclosure' by no later than 12.00 (noon) (Irish/UK time) on 2 September 2022 and disclose details of any 'dealings' by it or any person 'acting in concert' with it in 'relevant securities' of the Company by no later than 12.00 (noon) (Irish/UK time) on the business day following the date of the transaction.

All 'dealings' in 'relevant securities' of the Company by Lone Star, or by any party acting in concert with Lone Star, must also be disclosed by no later than 12 noon (Irish/UK time) on the 'business' day following the date of the relevant transaction. If two or more persons co‑operate on the basis of an agreement, either express or tacit, either oral or written, to acquire for one or more of them an interest in relevant securities, they will be deemed to be a single person for these purposes.

Disclosure tables, giving details of the companies in whose 'relevant securities' 'opening positions' and 'dealings' should be disclosed, can be found on the Irish Takeover Panel's website at www.irishtakeoverpanel.ie.

'Interests' in securities arise, in summary, when a person has long economic exposure, whether conditional or absolute, to changes in the price of securities. In particular, a person will be treated as having an 'interest' by virtue of the ownership or control of securities, or by virtue of any option in respect of, or derivative referenced to, securities.

Terms in quotation marks in this section are defined in the Irish Takeover Rules, which can also be found on the Irish Takeover Panel's website. If you are in any doubt as to whether or not you are required to disclose a dealing or an opening position under Rule 8, please consult the Irish Takeover Panel's website at www.irishtakeoverpanel.ie or contact the Irish Takeover Panel on telephone number +353 1 678 9020.

Disclosure requirements of the Cypriot Takeover Bids Law

In addition to the requirements under Rule 8 of the Irish Takeover Rules as outlined above, under section 26 of the Cypriot Takeover Bids Law, during the 'period of the takeover bid':

a) Lone Star and every person holding a percentage of five per cent (5%) or more of the voting rights of the Company or Lone Star, must announce immediately, in accordance with the provisions of the Cypriot Takeovers Bids Law, every acquisition of securities in the Company or Lone Star made by themselves or by persons acting in their own name but on their behalf or in concert with them or by undertakings controlled by them, as well as the acquisition price and any voting rights already held in that company; and

b) every person acquiring a percentage equal to half per cent (0.5%) or greater of the voting rights of the Company or Lone Star, must make an announcement for this acquisition in accordance with the provisions of the Cypriot Takeovers Bids Law, as well as every subsequent acquisition of securities of these companies by themselves or by persons acting in their own name but on their behalf or in concert with them or by undertakings controlled by them, as well as the acquisition price and any voting rights already held in that company.

Terms in quotation marks in this section are defined in the Cypriot Takeover Bids Law, which can also be found on the website of the Securities and Exchange Commission of Cyprus at www.cysec.gov.cy.

Profit Forecast / Asset Valuations / Quantified Financial Benefit Statement

The financial results for the period ended 30 June 2022 provided in this document constitute a profit estimate for the purposes of the Irish Takeover Rules and are subject to Rule 28.5. Other than the foregoing, no statement in this document is intended to constitute a profit forecast for any period, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. No statement in this document constitutes an asset valuation or quantified financial benefit statement.

Non‑IFRS performance measures

Bank of Cyprus Holdings Public Limited Company's (the Company) management believes that the non‑IFRS performance measures included in this document provide valuable information to the readers of the Interim Financial Report as they enable the readers to identify a more consistent basis for comparing the Group's performance between financial periods and provide more detail concerning the elements of performance which management are directly able to influence or are relevant for an assessment of the Group. They also reflect an important aspect of the way in which the operating targets are defined and performance is monitored by the Group's management. However, any non‑IFRS performance measures in this document are not a substitute for IFRS measures and readers should consider the IFRS measures as the key measures of the 30 June position. Refer to 'Definitions and explanations on Alternative Performance Measures Disclosures' on pages 155 to 169 of the Interim Financial Report for the six months ended 30 June 2022 for further information, reconciliations with Consolidated Condensed Interim Financial Statements and calculations of non‑IFRS performance measures included throughout this document and the most directly comparable IFRS measures.

The Interim Financial Report for the six months ended 30 June 2022 is available on the Group's website www.bankofcyprus.com (Group/Investor Relations) (the Group's website).

The Interim Financial Report for the six months ended 30 June 2022 of the Group is originally issued in English. The Greek translation of the Interim Financial Report for the six months ended 30 June 2022 will be available on the Group's website from 31 August 2022. In case of a difference or inconsistency between the English document and the Greek document, the English document prevails.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR SDFSIFEESELA
Date   Source Headline
2nd May 20247:28 amRNSBOCH - Transactions in Own Shares
2nd May 20247:20 amRNSBOCH – Total voting rights and Capital
30th Apr 202410:19 amRNSAppointments of New Directors
30th Apr 20247:02 amRNSTransaction in Own Shares
29th Apr 20247:15 amRNSBOCH - Transactions in Own Shares
26th Apr 20241:21 pmRNSDate of announcement of 1Q2024 FR
26th Apr 20247:03 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:26 amRNSBOCH - Transactions in Own Shares
25th Apr 20247:00 amRNSIssue of Green Senior Preferred Notes by BOC PCL
24th Apr 20247:00 amRNSBOCH - Transaction in Own Shares
24th Apr 20247:00 amRNSTR1 Notification - Helikon
24th Apr 20247:00 amRNSTR1 Notification -Helikon
23rd Apr 20247:25 amRNSBOCH - Transactions in Own Shares
22nd Apr 20247:27 amRNSBOCH - Transactions in Own Shares
19th Apr 20247:41 amRNSLaunch of share buyback programme
12th Apr 202410:02 amRNSNotice of AGM
5th Apr 20247:20 amRNS2023 Pillar 3 Disclosures
2nd Apr 20241:21 pmRNSTR1 Notification of Holdings - OSOME
2nd Apr 202412:59 pmRNSTR1 Notification of Holdings - OSOME
28th Mar 20242:24 pmRNSBOC Annual Financial Report 2023 Announcement
28th Mar 20241:31 pmRNSBOCH Annual Financial Report 2023 Announcement
28th Mar 20241:30 pmRNSFY2023 Investor Presentation Announcement
28th Mar 20241:30 pmRNSFY2023 Group Financial Results
20th Mar 20247:00 amRNSAnnouncement of Distribution
15th Mar 20249:21 amRNSDate of Announcement of Audited FY2023 FS
19th Feb 20247:01 amRNSDoc re. (Prelim FY2023 Investor Presentation)
19th Feb 20247:00 amRNSPreliminary FY2023 Group Financial Results
6th Feb 20248:41 amRNSDate of announcement of Preliminary FY2023 FR
22nd Dec 20239:09 amRNSRevised Date of AGM
20th Dec 20238:32 amRNSChanges in the composition of the BOD & Committees
13th Dec 20237:00 amRNSEU-wide Transparency Exercise 2023
11th Dec 20232:51 pmRNSChanges in the composition of the BOD
29th Nov 202310:28 amRNSDecision to call AT1 Capital Securities
29th Nov 20238:19 amRNSDate of Annual General Meeting
20th Nov 20239:58 amRNSAppointment of New Director
13th Nov 20237:00 amRNSDoc re. (9M2023 Investor Presentation)
13th Nov 20237:00 amRNS9M2023 Group Financial Results
27th Oct 20237:17 amRNSDate of announcement of 9M2023 FR
24th Oct 202312:41 pmRNSTR1 Notification - Caius
13th Oct 202312:27 pmRNSChanges in the composition of the BODs
27th Sep 20238:28 amRNSDirectorate Change
31st Aug 20237:37 amRNSChanges in the composition of BOD
11th Aug 20239:55 amRNSAppointment of new director
21st Jul 202310:43 amRNSDate of announcement of 1H2023 FR
18th Jul 20234:43 pmRNSIssue of Senior Preferred Notes
3rd Jul 202311:48 amRNSBuyback of Additional Tier 1 Capital Securities
23rd Jun 202312:48 pmRNSComposition of the Boards of Directors
20th Jun 202312:22 pmRNSResults of Additional Tier 1 Tender Cash Offer
19th Jun 202312:34 pmRNSTR1 Notification of Major Holdings - Caius
13th Jun 20233:43 pmRNSRefinancing of AT1 Capital Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.